小鼠海马神经元HT22细胞系中可调控Crat过表达系统的构建
本研究于2025年1月至11月在小鼠海马神经元HT22细胞系中构建四环素诱导型Crat过表达慢病毒系统,比较CMV与EF1A启动子驱动效率。EF1A启动子阳性细胞数显著高于CMV启动子。在H₂O₂氧化损伤模型中,Dox诱导的Crat过表达组LDH释放率、TUNEL凋亡细胞率及Caspase-3、Bax mRNA水平均低于未感染Dox组,Bcl-2 mRNA水平高于未感染Dox组。
要点
- EF1A启动子驱动效率优于CMV启动子,阳性细胞数更多。
- Dox诱导Crat过表达可降低H₂O₂损伤后LDH释放率和凋亡细胞率。
- Crat过表达下调Caspase-3和Bax mRNA,上调Bcl-2 mRNA。
核心结论
- 成功在小鼠海马神经元HT22细胞系中建立可控的Crat过表达平台,可实现Crat基因表达的时序调控。
研究设计与样本
- 实验研究,于2025年1月至11月使用小鼠海马神经元HT22细胞系,通过优化MOI和聚凝胺浓度及比较CMV与EF1A启动子,建立四环素诱导型慢病毒表达系统。
主要发现
- EF1A启动子组阳性细胞数(303.0±28.0)个高于CMV启动子组(88.7±11.4)个,t=17.37,P<0.001。
- H₂O₂损伤模型中,感染添加Dox组LDH释放率27.1%±4.7%低于未感染添加Dox组49.8%±8.2%,P<0.001。
- 感染添加Dox组TUNEL凋亡细胞率14.1%±3.4%低于未感染添加Dox组41.3%±4.1%,t=16.23,P<0.001。
- 感染添加Dox组Caspase-3 mRNA水平140.3±17.1低于未感染添加Dox组192.0±24.3,t=4.26,P=0.002。
- 感染添加Dox组Bax mRNA水平132.0±13.1低于未感染添加Dox组169.8±12.6(t=5.09,P<0.001),Bcl-2 mRNA水平83.2±6.9高于未感染添加Dox组58.3±8.1(t=5.74,P<0.001)。
临床怎么用
- 该可控Crat过表达平台可用于青光眼神经保护研究中Crat基因功能的细胞特异性与时序性研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To construct an inducible carnitine acetyltransferase (Crat) gene expression system and provide a controllable experimental platform for research on neuroprotection in glaucoma. Methods: This experimental study was conducted from January 2025 to November 2025 using the mouse hippocampal neuronal HT22 cell line. A high-efficiency tetracycline-inducible lentiviral gene expression system was established by optimizing the multiplicity of infection (MOI) and polybrene concentration, as well as comparing the activities of the cytomegalovirus (CMV) promoter and the elongation factor 1α (EF1A) promoter. According to promoter type, the cells were divided into two groups: the CMV promoter group, in which enhanced green fluorescent protein (EGFP) fluorescence was detected, and the EF1A promoter group, in which mCherry fluorescence was detected. Conditional Crat overexpression was induced by doxycycline (Dox). Unmodified HT22 cells were assigned to an uninfected control group and an uninfected Dox-treated group, whereas successfully constructed HT22-TRE-mCrat/rtTA cells were assigned to an infected non-Dox-treated group and an infected Dox-treated group. The neuroprotective effect of the Crat overexpression system was evaluated in an H2O2-induced oxidative injury model by measuring lactate dehydrogenase (LDH) release, terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) staining, and the mRNA expression levels of apoptosis-related factors, including caspase-3, B-cell lymphoma 2-associated X protein (Bax), and B-cell lymphoma 2 (Bcl-2), using quantitative PCR (qPCR). Statistical analyses were performed using the independent-samples t-test or one-way analysis of variance, with Tukey's test for pairwise comparisons. Results: A tetracyline-inducible gene expression system was successfully constructed and stably established in HT22 cells. The EF1A promoter showed higher driving efficiency than the CMV promoter, with a significantly greater number of positive cells in the EF1A promoter group than in the CMV promoter group [(303.0±28.0) vs. (88.7±11.4) cells; t=17.37, P<0.001]. In the H₂O₂-induced oxidative injury model, the LDH release rate was significantly lower in the infected Dox-treated group than in the uninfected Dox-treated group (27.1%±4.7% vs. 49.8%±8.2%; P<0.001). The apoptotic cell rate determined by TUNEL staining was significantly lower in the infected Dox-treated group than in the uninfected Dox-treated group (14.1%±3.4% vs. 41.3%±4.1%; t=16.23, P<0.001). The caspase-3 mRNA level was significantly lower in the infected Dox-treated group than in the uninfected Dox-treated group (140.3±17.1 vs. 192.0±24.3; t=4.26, P=0.002). Bax mRNA expression was significantly lower in the infected Dox-treated group than in the uninfected Dox-treated group (132.0±13.1 vs. 169.8±12.6; t=5.09, P<0.001). Bcl-2 mRNA expression was significantly higher in the infected Dox-treated group than in the uninfected Dox-treated group (83.2±6.9 vs. 58.3±8.1; t=5.74, P<0.001). All of these differences were statistically significant. Conclusion: This study successfully established a controllable Crat overexpression platform using the mouse hippocampal neuronal HT22 cell line, enabling temporal regulation of Crat gene expression and cell-specific studies in this cell line. 目的: 构建可调控的肉碱乙酰转移酶(Crat)过表达基因系统。 方法: 实验研究。于2025年1月至11月,采用小鼠海马神经元细胞系HT22进行实验。通过优化慢病毒感染复数(MOI)及聚凝胺浓度,比较巨细胞病毒(CMV)与延伸因子1α(EF1A)启动子驱动效率,建立高效四环素诱导型(Tet-On)慢病毒基因表达系统。根据启动子类型,将细胞分为两组:CMV启动子组(检测EGFP荧光)和EF1A启动子组(检测mCherry荧光)。经多西环素(Dox)诱导后实现Crat条件性过表达。将普通HT22细胞分为未感染对照组和未感染添加Dox组;将已成功构建的HT22-TRE-mCrat/rtTA细胞分为感染未添加Dox组及感染添加Dox组。利用H₂O₂诱导的氧化损伤模型,通过乳酸脱氢酶(LDH)释放、末端脱氧核苷酸转移酶标记法(TUNEL)染色及qPCR检测凋亡相关因子半胱天冬酶-3(Caspase-3)、B淋巴细胞瘤-2相关X蛋白(Bax)、B淋巴细胞瘤-2(Bcl-2)的mRNA表达水平,评价Crat过表达系统的神经保护作用。采用独立样本t检验和单因素方差分析进行统计学分析。 结果: 成功在HT22细胞中构建并稳定表达Tet-On可诱导基因表达系统。EF1A启动子驱动效率优于CMV启动子,EF1A启动子组阳性细胞数[(303.0±28.0)个]高于CMV启动子组[(88.7±11.4)个],差异有统计学意义(t=17.37,P<0.001)。在H₂O₂氧化损伤模型中,感染添加Dox组LDH释放率(27.1%±4.7%)低于未感染添加Dox组(49.8%±8.2%),差异有统计学意义(P<0.001);TUNEL染色凋亡细胞率(14.1%±3.4%)低于未感染添加Dox组(41.3%±4.1%),差异有统计学意义(t=16.23,P<0.001);Caspase-3 mRNA水平(140.3±17.1)低于未感染添加Dox组(192.0±24.3;t=4.26,P=0.002);Bax mRNA表达水平(132.0±13.1)低于未感染添加Dox组(169.8±12.6;t=5.09,P<0.001);Bcl-2 mRNA表达水平(83.2±6.9)高于未感染添加Dox组(58.3±8.1;t=5.74,P<0.001)。 结论: 采用小鼠海马神经元细胞系HT22成功建立了可控的Crat过表达平台,可在该细胞系中实现对Crat基因表达的时序调控与细胞特异性研究。.
引用
- Dong XX, Lin HL, Jian YH, et al. [Construction of a regulated Crat overexpression system in mouse hippocampal neuronal HT22 cell line]. Zhonghua Yan Ke Za Zhi. 2026. PMID: 42379864. doi:10.3760/cma.j.cn112142-20251111-00479
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。